Numerous studies implicate the ventral medulla (VM) in narcotic analgesia and stimulation produced-analgesia. Preliminary studies report for the first time a newly identified descending analgesia system originating in VM, the bulbospinal substance P (SP) system. The role of this newly identified descending SP analgesia pathway in pain inhibition will be explored in proposed recording studies. The ability of SP antagonists and serotonin (5-HT) antagonists to block VM inhibition of dorsal horn nociceptive units will be quantitatively assessed, allowing the quantification of the relative contributions of bulbospinal SP and 5-HT systems in pain inhibition. The unique design of the recording studies will permit primary afferent SP input to be contrasted with bulbospinal SP input to the same dorsal horn neuron. The interaction of the bulbospinal SP and 5-HT systems will also be explored in recording studies employing 5,7-DHT treated animals to selectively destroy spinal 5-HT fibers. In our working model the descending 5-HT system plays an important interactive role in bulbospinal SP-mediated pain inhibition. A second group of experiments are proposed to pharmacologically define the 5-HT receptor subtype associated with this bulbospinal 5-HT analgesia system. Proposed receptor binding and recording studies will pharmacologically characterize the 5-HT receptor subtype (1A or 1B) associated with the descending 5-HT analgesia pathway. Proposed receptor binding competition experiments will characterize dorsal horn 1A and 1B 5-HT receptor subtypes and identify the most selective 1A and 1B agonists and antagonists for use in subsequent recording studies. These recording studies will determine the 5-HT1 receptor subtype mediating inhibition of dorsal horn nociceptive unit activity. In addition to the importance of these studies for pain research, they will provide an understanding of receptor structure/function relationships rarely seen in the CNS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS018326-04A2
Application #
3398365
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1983-04-01
Project End
1990-08-31
Budget Start
1987-09-15
Budget End
1988-08-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Murphy, R M; Zemlan, F P (1992) Quantitative autoradiographic mapping of a novel serotonin receptor-5-HT1S. Neuroreport 3:837-40
Zemlan, F P; Schwab, E F (1991) Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein. J Neurochem 57:2092-9
Murphy, R M; Zemlan, F P (1990) Selective serotonin1A/1B agonists differentially affect spinal nociceptive reflexes. Neuropharmacology 29:463-8
Behbehani, M M; Zemlan, F P (1990) Bulbospinal and intraspinal thyrotropin releasing hormone systems: modulation of spinal cord pain transmission. Neuropeptides 15:161-8
Zemlan, F P; Garver, D L (1990) Depression and antidepressant therapy: receptor dynamics. Prog Neuropsychopharmacol Biol Psychiatry 14:503-23
Murphy, R M; Zemlan, F P (1988) Selective 5-HT1B agonists identify the 5-HT autoreceptor in lumbar spinal cord of rat. Neuropharmacology 27:37-42
Murphy, R M; Zemlan, F P (1987) Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology (Berl) 93:118-21
Zemlan, F P; Hirschowitz, J; Sautter, F et al. (1986) Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine. Psychiatry Res 18:239-55
Zemlan, F P; Hitzemann, R J; Hirschowitz, J et al. (1985) Down-regulation of central dopamine receptors in schizophrenia. Am J Psychiatry 142:1334-7